A U.S. Patent Application for a “Method for Determining the InVivo Comparability of a Biologic Drug and a Reference Drug” was published by Bioanalytix on March 7th, 2019. The present invention provides a mass-spectroscopic approach for assessing and determining the in vivo comparability of a candidate biologic molecule to a reference biologic molecule. The results can be presented in the form of an in vivo comparability profile, which can serve as a development tool, e.g., as a guide or target for the development of biologies, biosimilars, or gene therapy-based drugs. Learn More